Regulatory News
Thursday, November 24, 2016
Costly leukaemia pill wins UK green light after price cut
LONDON, Nov 25 (Reuters) - A costly blood cancer pill sold
in Europe by Johnson & Johnson will be made routinely
available to certain patients in Britain with chronic
lymphocytic leukaemia, after the...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment